TEL/ETV6 accelerates erythroid differentiation and inhibits megakaryocytic maturation in a human leukemia cell line UT-7/GM

Cancer Science

Volumn 96, Issue 6, 2005, Pages 340-348

  Takahashi, Wataru ^a   Sasaki, Ko ^a   Komatsu, Norio ^b   Mitani, Kinuko ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GAMMA GLOBIN; GLYCOPHORIN A; GLYCOPROTEIN IIB; HEMOGLOBIN; THROMBOCYTE FACTOR 4; THROMBOPOIETIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETV6; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; DOWN REGULATION; ERYTHROID CELL; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HEMOGLOBIN SYNTHESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MEGAKARYOCYTE; PRIORITY JOURNAL; STEM CELL;

CELL DIFFERENTIATION; DNA-BINDING PROTEINS; DOWN-REGULATION; ERYTHROCYTES; ERYTHROPOIETIN; HUMANS; LEUKEMIA; MEGAKARYOCYTES; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; THROMBOPOIETIN; TUMOR CELLS, CULTURED;

EID: 22444440087     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2005.00052.x     Document Type: Article

References (37)

1. Golub TR, Barker GF, Lovett M, Gilliland DG. Fusion of PDGF receptor β to a novel ets-like gene, [i#Tel#1i], in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. [i#Cell#1i] 1994; [b#77#1b]: 307-316.
2. Kwiatkowski BA, Bastian LS, Bauer TR, Jr, Tsai S, Zielinska-Kwiatkowska AG, Hickstein DD. The [i#ets#1i] family member Tel binds to the Fli-1 oncoprotein and inhibits its transcriptional activity. [i#J Biol Chem#1i] 1998; [b#273#1b]: 17525-30.
3. Potter MD, Buijs A, Kreider B, van Rompaey L, Grosveld GC. Identification and characterization of a new human ETS-family transcription factor, [i#TEL2#1i], that is expressed in hematopoietic tissues and can associate with [i#TEL1/ETV6. Blood#1i] 2000; [b#95#1b]: 3341-8.
4. Wang L, Hiebert SW. TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3. [i#Oncogene#1i] 2001; [b#20#1b]: 3716-25.
5. Martinez R, Golub TR. [i#Blood#1i] 2000; [b#96#1b]: 453a.
6. Fenrick R, Wang L, Nip J [i#et al.#1i] TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of [i#Stromelysin-1. Mol Cell Biol#1i] 2000; [b#20#1b]: 5828-39.
7. L. [i#J Biol Chem#1i] 2000; [b#278#1b]: 46378-86.
8. Arai H, Maki K, Waga K [i#et al.#1i] Functional regulation of TEL by p38-induced phosphorylation. [i#Biochem Biophys Res Commun#1i] 2002; [b#299#1b]: 116-25.
9. Maki K, Arai H, Waga K [i#et al.#1i] Leukemia-related transcription factor TEL is negatively regulated through extracellular signal-regulated kinase-induced phosphorylation. [i#Mol Cell Biol#1i] 2004; [b#24#1b]: 3227-37.
10. Wood LD, Irvin BJ, Nucifora G, Luce KS, Hiebert SW. Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressor. [i#Proc Natl Acad Sci USA#1i] 2003; [b#100#1b]: 3257-62.
11. Chakrabarti SR, Sood R, Nandi S, Nucifora G. Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies. [i#Proc Natl Acad Sci USA#1i] 2000; [b#97#1b]: 13281-5.
12. Jousset C, Carron C, Boureux A [i#et al.#1i] A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFRβ oncoprotein. [i#EMBO J#1i] 1997; [b#16#1b]: 69-82.
13. Golub TR, Goga A, Barker GF [i#et al.#1i] Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. [i#Mol Cell Biol#1i] 1996; [b#16#1b]: 4107-16.
14. Cazzaniga G, Tosi S, Aloisi A [i#et al.#1i] The tyrosine kinase [i#abl#1i]-related gene [i#ARG#1i] is fused to [i#ETV6#1i] in an AML-M4Eo patient with a t(1;12) (q25;p13): molecular cloning of both reciprocal transcripts. [i#Blood#1i] 1999: 94: 4370-3.
15. Lacronique V, Boureux A, Valle VD [i#et al.#1i] A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. [i#Science#1i] 1997; [b#278#1b]: 1309-12.
16. Kano Y, Abe A, Emi N [i#et al.#1i] Constitutive kinase activation of the [i#TEL-Syk#1i] fusion gene in myelodysplastic syndrome with t(9;12) (q22;p12). [i#Blood#1i] 2001: [b#97#1b]: 1050-5.
17. Hiebert SW, Sun W, Davis JN [i#et al.#1i] The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. [i#Mol Cell Biol#1i] 1996: [b#16#1b]: 1349-55.
18. Wang LC, Kuo F, Fujiwara Y, Gilliland DG, Golub TR, Orkin SH. Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. [i#EMBO J#1i] 1997; [b#16#1b]: 4374-83.
19. Wang LC, Swat W, Fujiwara Y [i#et al.#1i] The [i#TEL/ETV6#1i] gene is required specifically for hematopoiesis in the bone marrow. [i#Genes Dev#1i] 1998; [b#12#1b]: 2392-402.
20. Waga K, Nakamura Y, Maki K [i#et al.#1i] Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells. [i#Oncogene#1i] 2003; [b#22#1b]: 59-68.
21. Komatsu N, Kirito K, Shimizu R [i#et al.#1i] In vitro development of erythroid and megakaryocytic cells from a UT-7 subline, UT-7/GM. [i#Blood#1i] 1997; [b#89#1b]: 4021-33.
22. Komatsu N, Nakauchi H, Miwa A [i#et al.#1i] Establishment and characterization of a human leukemic cell line with megakaryocytic features dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival. [i#Cancer Res#1i] 1991; [b#51#1b]: 341-8.
23. Breton-Gorius J, Guichard J. Ultrastructural localization of peroxidase activity in human platelets and megakaryocytes. [i#Am J Pathol#1i] 1972; [b#66#1b]: 277-93.
24. Zhang C, Thornton MA, Kowalska MA [i#et al.#1i] Localization of distal regulatory domains in the megakaryocyte-specific platelet basic protein/platelet factor 4 gene locus. [i#Blood#1i] 2001; [b#98#1b]: 610-7.
25. Lemarchandel V, Ghysdael J, Mignotte V, Rahuel C, Romeo PH. GATA and Ets [i#cis#1i]-acting sequences mediate megakaryocyte-specific expression. [i#Mol Cell Biol#1i] 1993; [b#13#1b]: 668-76.
26. Lu J, Pazin MJ, Ravid K. Properties of ets-1 binding to chromatin and its effect on platelet factor 4 gene expression. [i#Mol Cell Biol#1i] 2004; [b#24#1b]: 428-41.
27. Ben-David Y, Giddens EB, Letwin K, Bernstein A. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. [i#Genes Dev#1i] 1991; [b#5#1b]: 908-18.
28. Athanasiou M, Mavrothalassitis G, Sun-Hoffman L, Blair DG. FLI-1 is a suppressor of erythroid differentiation in human hematopoietic cells. [i#Leukemia#1i] 2000; [b#14#1b]: 439-45.
29. Tamir A, Howard J, Higgins RR [i#et al.#1i] Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the [i#Rb#1i] gene during differentiation. [i#Mol Cell Biol#1i] 1999; [b#19#1b]: 4452-64.
30. Starck J, Cohet N, Gonnet C [i#et al.#1i] Functional cross-antagonism between transcription factors FLI-1 and EKLF. [i#Mol Cell Biol#1i] 2003; [b#23#1b]: 1390-402.
31. Hart A, Melet F, Grossfeld P [i#et al.#1i] Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. [i#Immunity#1i] 2000; [b#13#1b]: 167-77.
32. Bastian LS, Kwiatkowski BA, Breininger J, Danner S, Roth G. Regulation of the megakaryocytic glycoprotein IX promoter by the oncogenic Ets transcription factor Fli-1. [i#Blood#1i] 1999; [b#93#1b]: 2637-44.
33. Deveaux S, Filipe A, Lemarchandel V, Ghysdael J, Romeo PH, Mignotte V. Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes. [i#Blood#1i] 1996; [b#87#1b]: 4678-85.
34. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. [i#Cell#1i] 1990; [b#61#1b]: 49-59.
35. Lister J, Forrester WC, Baron MH. Inhibition of an erythroid differentiation switch by the helix-loop-helix protein Id1. [i#J Biol Chem#1i] 1995; [b#270#1b]: 17939-46.
36. Kreider BL, Benezra R, Rovera G, Kadesch T. Inhibition of myeloid differentiation by the helix-loop-helix protein Id. [i#Science#1i] 1992; [b#255#1b]: 1700-2.
37. Pongubala JM, Atchison ML. Functional characterization of the developmentally controlled immunoglobulin kappa-3′ enhancer. regulation by Id, a repressor of helix-loop-helix transcription factors. [i#Mol Cell Biol#1i] 1991; [b#11#1b]: 1040-7.